Transgenic mouse models of dopamine deficiency
โ Scribed by Linan Chen; Xiaoxi Zhuang
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 108 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The generation of mice designed to overexpress activated forms of oncogenes or carrying targeted mutations in tumour suppressor genes, has allowed scientists to causally link the function of these genes with specific tumour processes, such as proliferation, apoptosis, angiogenesis or metastasis. In
Novel gene technologies have allowed us to manipulate the genetic balance of candidate molecules in mice in a controllable manner. Homologous or site-speciยฎc recombination in embryonic stem cells allows us to study the consequences of deยฎciencies, mutations, and conditional or tissue-speciยฎc express
## Abstract Parkinson's disease (PD) is characterized by loss of nigral dopaminergic (DAergic) neurons and presence of Lewy bodies, whose major component is ฮฑโsynuclein. We had previously generated transgenic mice termed __Syn130m__ that express truncated human ฮฑโsynuclein (amino acid residues 1โ13